Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro

被引:0
作者
Wujiang Liu
Michael A. O’Donnell
Xiaohong Chen
Ruifa Han
Yi Luo
机构
[1] University of Iowa,Department of Urology
[2] Tainjin Institute of Urology,undefined
来源
Cancer Immunology, Immunotherapy | 2009年 / 58卷
关键词
BCG; IFN-α; Bladder cancer; Cytotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1647 / 1655
页数:8
相关论文
共 267 条
  • [1] Lamm DL(1980)Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer J Urol 124 38-40
  • [2] Thor DE(1995)Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse Surg Oncol Clin N Am 4 189-202
  • [3] Harris SC(1999)BCG immunotherapy of bladder cancer: 20 years on Lancet 353 1689-1694
  • [4] Reyna JA(1990)Effects of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall J Urol 144 53-58
  • [5] Stogdill VD(1992)Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall J Urol 147 1636-1642
  • [6] Radwin HM(1989)Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical bacillus Calmette-Guérin Urol Res 17 299-303
  • [7] O’Donnell MA(2001)Evaluation of cellular tumor rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment BJU Int 88 602-610
  • [8] DeWolf DC(1991)Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin Cancer Immunol Immunother 33 411-416
  • [9] Alexandroff AB(1991)Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis Urol Res 19 45-50
  • [10] Jackson AM(1990)Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy J Urol 144 59-64